CN Patent

CN114650809A — 屈大麻酚的透皮递送

Assigned to Staten Therapy · Expires 2022-06-21 · 4y expired

What this patent protects

提供了一种包含屈大麻酚的透皮药物递送系统。所述屈大麻酚透皮递送系统在预定时间段内以预定速率提供药物血浆浓度，从而通过降低给药频率为治疗和/或预防与例如化学疗法相关的恶心和/或呕吐提供简化治疗方案。

USPTO Abstract

提供了一种包含屈大麻酚的透皮药物递送系统。所述屈大麻酚透皮递送系统在预定时间段内以预定速率提供药物血浆浓度，从而通过降低给药频率为治疗和/或预防与例如化学疗法相关的恶心和/或呕吐提供简化治疗方案。

Drugs covered by this patent

Patent Metadata

Patent number
CN114650809A
Jurisdiction
CN
Classification
—
Expires
2022-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Staten Therapy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.